GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-20 22:10 |
GENFIT Annual Combined General Meeting of May 25, 2022 — Availability of Prepa…
|
English | 141.7 KB | ||
| 2022-04-07 22:10 |
GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update
|
English | 406.3 KB | ||
| 2022-04-07 22:10 |
GENFIT : Résultats financiers annuels 2021 et point sur les activités de la Soc…
|
French | 383.7 KB | ||
| 2022-02-28 22:10 |
GENFIT Annonce un Chiffre d’Affaires et une Position de Trésorerie robustes au …
|
French | 179.6 KB | ||
| 2022-02-28 22:10 |
GENFIT Announces Solid Revenues and Cash Position as of December 31, 2021
|
English | 203.1 KB | ||
| 2022-01-24 22:10 |
GENFIT: 2022 Financial Calendar
|
English | 143.6 KB | ||
| 2022-01-24 22:10 |
GENFIT annonce son calendrier financier pour 2022
|
French | 114.8 KB | ||
| 2022-01-21 22:10 |
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commer…
|
English | 291.3 KB | ||
| 2022-01-21 22:10 |
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Indu…
|
French | 283.5 KB | ||
| 2021-12-24 16:00 |
Franchissement de seuils
|
French | 116.4 KB | ||
| 2021-12-17 07:15 |
On heels of global strategic partnership announced today, GENFIT acquires right…
|
English | 172.9 KB | ||
| 2021-12-17 07:15 |
GENFIT : A la suite du partenariat stratégique global annoncé ce jour, GENFIT a…
|
French | 137.8 KB | ||
| 2021-12-17 07:00 |
GENFIT : Ipsen et GENFIT concluent un accord de licence exclusif pour elafibran…
|
French | 188.3 KB | ||
| 2021-12-17 07:00 |
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibran…
|
English | 182.1 KB | ||
| 2021-11-18 22:15 |
GENFIT : Une étude menée par FNIH NIMBLE démontre la performance unique de la t…
|
French | 181.9 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
